Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy
Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.
Kathy Idoine
If highest risk includes those of us with transplants, why is this group being disregarded from the studies and consideration for approval of the drugs by pharmaceutical companies?
October 9, 2014 • Santa Cruz